NASDAQ: ZCMDZhongchao Inc Stock
$1.38+0.01 (+0.73%)
Updated May 15, 2024
ZCMD Price
$1.38
Fair Value Price
N/A
Market Cap
$3.59M
52 Week Low
$1.20
52 Week High
$13.00
P/E
-0.32x
P/B
0.2x
P/S
0.47x
PEG
N/A
Dividend Yield
N/A
Revenue
$19.43M
Earnings
-$11.34M
Gross Margin
43.8%
Operating Margin
-61.78%
Profit Margin
-58.3%
Debt to Equity
0.19
Operating Cash Flow
$54k
Beta
0.28
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ZCMD Overview
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.
Zen Score
–
Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ZCMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZCMD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZCMD is good value based on its book value relative to its share price (0.2x), compared to the US Health Information Services industry average (3.37x)
P/B vs Industry Valuation
ZCMD is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ZCMD due diligence checks available for Premium users.
Be the first to know about important ZCMD news, forecast changes, insider trades & much more!
ZCMD News
Valuation
ZCMD fair value
Fair Value of ZCMD stock based on Discounted Cash Flow (DCF)
Price
$1.38
Fair Value
-$1.08
Undervalued by
227.41%
ZCMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ZCMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.32x
Industry
10.02x
Market
31.36x
ZCMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.2x
Industry
3.37x
ZCMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ZCMD's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ZCMD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ZCMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$24.4M
Liabilities
$3.4M
Debt to equity
0.19
ZCMD's short-term assets ($18.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZCMD's short-term assets ($18.71M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZCMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ZCMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ZCMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ZCMD vs Health Information Service Stocks
Zhongchao Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.